Fundraising FoxMirata Pharmaceuticals
Plymouth Meeting, US · Founded 2016 · 1 known investors
Find your way into Mirata Pharmaceuticals
Sign up to see every warm intro you have to Mirata Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mirata Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects. It targets patients and physicians seeking safer alternatives to prescription opioids.
Founders & leadership
JJ
John JohnsonNamed on SEC filing
BH
Brian HubbardNamed on SEC filing
JY
Jason Y ZhangNamed on SEC filing
MG
Maurits GeerlingsNamed on SEC filing
MC
Matthew CallahanNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.1M disclosed across 1 round · 2018
▶$7.1MraisedJan 2019 · 11 investors · PharmaceuticalsRule 506(b)
▶$7.1MraisedJan 2019 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John JohnsonDirector
- Joseph F LovettDirector
- Brian HubbardDirector
- Jason Y ZhangDirector
- Maurits GeerlingsDirector
- Matthew CallahanExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7.1M
- Proceeds to insiders
- $12.7K
- First sale
- Jun 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Mirata Pharmaceuticals do?
- Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects. It targets patients and physicians seeking safer alternatives to prescription opioids.
- Who are Mirata Pharmaceuticals's investors?
- Mirata Pharmaceuticals's investors include Louisiana Funds.
- How much funding has Mirata Pharmaceuticals raised?
- Mirata Pharmaceuticals has disclosed $7.1M raised across 1 round.
- Where is Mirata Pharmaceuticals headquartered?
- Mirata Pharmaceuticals is headquartered in Plymouth Meeting, US.